MYLK2
protein-codingmyosin light chain kinase 2, the group of Myosin light chain kinase family
Gene summary
This gene encodes a myosin light chain kinase, a calcium/calmodulin dependent enzyme, that is exclusively expressed in adult skeletal muscle. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~15.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008647
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0008647
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0008647
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0005045
Submitter: ClinGen
*MYLK2* was first reported in relation to hypertrophic cardiomyopathy (HCM) in humans as early as 2001(Davis et al., 2001 PMID: 11733062). To date, at least 5 unique variants (4 missense, 1 synonymous) have been reported in 4 probands with hypertrophic cardiomyopathy (Davis et al., 2001, PMID: 11733062; Wang et al., 2018, PMID: 29978770; Gonzalez-Garay et al., 2013, PMID:24082139; Burstein et al., 2021, PMID:32746448). However, these probands also carry additional variants in genes implicated in hypertrophic cardiomyopathy, including MYH7 and MYBPC3. No segregation data is available. The mechanism for disease is unknown, but predicted to be gain of function (GOF) from functional assays performed by Davis et al., 2001. This gene-disease relationship is supported by expression studies showing restricted expression of MYLK2 in skeletal muscle and heart and biochemical functional studies. The original curation was performed by the Hypertrophic Cardiomyopathy Gene Curation Expert Panel (GCEP) and published on January 18, 2017. In summary, there is no scored genetic evidence, and no new convincing evidence has emerged that contradicts the gene-disease relationship. More evidence is needed to either support or entirely refute the role MYLK2 plays in this disease. This classification was re-evaluated and approved by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel on February 8, 2023. As a result of this re-evaluation, the classification was changed from limited to disputed.
Inheritance Pattern: AD
Disease ID:MONDO:0024573
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular
Intervention: Cardiovascular
Rationale: Surveillance for cardiomyopathy (eg, with echocardiography/electrocardiography) and early medical treatment may reduce morbidity
Comments: Digenic inheritance (with MYH7) has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MYLK2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_033118.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 200 | 1 | 204 | ||
| missense | 377 | 31 | 1 | 409 | ||
| nonsense | 3 | 3 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 15 | 15 | ||||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 0 | 0 | 404 | 231 | 2 | 637 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_149109.1 | 12 | MANE Select | |
| Ensembl | ENSP00000365152.4 | 12 | MANE Select | |
| Ensembl | ENSP00000365162.2 | 12 | Standard | |
| Ensembl | ENSP00000365162.2 | 12 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Platelet activation - Homo sapiens (human)
- Focal adhesion - Homo sapiens (human)
- Oxytocin signaling pathway - Homo sapiens (human)
- Gastric acid secretion - Homo sapiens (human)
- Regulation of actin cytoskeleton - Homo sapiens (human)
Biological Process
- striated muscle contraction
- neuromuscular synaptic transmission
- positive regulation of gene expression
- skeletal muscle satellite cell differentiation
- peptidyl-threonine phosphorylation
Molecular Function
- calmodulin-dependent protein kinase activity
- myosin light chain kinase activity
- protein binding
- calmodulin binding
- ATP binding
Cellular Component
- nucleus
- cytoplasm
- sarcomere
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000375994
- Coding exons
- 12
- Length
- 15382
- Individuals with no LoFs
- 125724
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 23
- Defined
- 125748
- p
- 0.0000954
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.225 | 325 | 337 | 0.965 | 0.0000195 | 3914 |
| Missense (PolyPhen) | 101 | 117.16 | 0.86206 | 1428 | ||
| Synonymous | -0.342 | 144 | 139 | 1.04 | 0.00000935 | 1166 |
| Loss of Function | 3.50 | 6 | 24.8 | 0.242 | 0.00000117 | 319 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00012 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00027 | 0.00027 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000081 | 0.000079 | rare |
| South Asian | 0.00013 | 0.000098 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Implicated in the level of global muscle contraction and cardiac function. Phosphorylates a specific serine in the N- terminus of a myosin light chain. {ECO:0000269|PubMed:11733062}.;
Recessive Scores
- pRec
- 0.150
Intolerance Scores
- LoFtool
- 0.498
- RVIS EVS
- -0.24
- RVIS percentile EVS
- 36.23
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.947
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |